David S Ragsdale Selected Research

Type 1 Generalized Epilepsy With Febrile Seizures Plus

12/2002

Functional and biochemical analysis of a sodium channel beta1 subunit mutation responsible for generalized epilepsy with febrile seizures plus type 1.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

David S Ragsdale Research Topics

Disease

4	Seizures (Absence Seizure) 04/2010 - 12/2003
4	Epilepsy (Aura) 04/2010 - 02/2003
3	Epileptic Syndromes 05/2005 - 12/2002
2	Neuralgia (Stump Neuralgia) 02/2011 - 04/2010
2	Status Epilepticus (Complex Partial Status Epilepticus) 07/2008 - 12/2003
2	Generalized Epilepsy with Febrile Seizures Plus 05/2005 - 02/2003
1	Hypersensitivity (Allergy) 02/2011
1	Migraine Disorders (Migraine) 04/2010
1	Neurodegenerative Diseases (Neurodegenerative Disease) 04/2010
1	Multiple Sclerosis 04/2010
1	Nervous System Diseases (Neurological Disorders) 04/2010
1	Temporal Lobe Epilepsy 12/2003
1	Type 1 Generalized Epilepsy With Febrile Seizures Plus 12/2002

Drug/Important Bio-Agent (IBA)

5	Voltage-Gated Sodium ChannelsIBA 04/2010 - 12/2002
4	Sodium Channels (Sodium Channel)IBA 06/2008 - 12/2002
2	Anticonvulsants (Antiepileptic Drugs)IBA 04/2010 - 05/2005
2	Phenytoin (Dilantin)FDA LinkGeneric 04/2010 - 05/2005
2	Pilocarpine (Ocusert)FDA LinkGeneric 07/2008 - 12/2003
2	SodiumIBA 06/2008 - 12/2003
1	calphostin CIBA 02/2011
1	StaurosporineIBA 02/2011
1	Purinergic P2X3 ReceptorsIBA 02/2011
1	Carbamazepine (Tegretol)FDA LinkGeneric 04/2010
1	Lamotrigine (Lamictal)FDA LinkGeneric 04/2010
1	Diazepam (Valium)FDA LinkGeneric 07/2008
1	LithiumIBA 12/2003
1	Tryptophan (L-Tryptophan)FDA Link 12/2002
1	Cysteine (L-Cysteine)FDA Link 12/2002

Therapy/Procedure

1	Ligation 02/2011